fren

2022-2025 Research Funding Competition

SCN’s national research funding competition supports world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians.

In September 2021, SCN launched Round 1 2022-2025 research competition that offered two and three-year awards. The second, to launch in September 2022, will offer two-year awards.

The application process for Round 1 2022-2025 is closed.

View the Round 1 results on our Research Competition Results page.

Research programs offered in Round 1:

  1. Early Career Researcher Jump-Start Awards
    Supporting early career researchers (within the first five years of an initial academic appointment) to develop a research program with a regenerative medicine focus.
  1. Impact Awards
    Supporting proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.
  1. Clinical Trial Awards
    Supporting early-stage clinical trial projects with high translational potential.
  1. Translation and Society Team Award
    Supporting high-calibre ELSI research teams to undertake innovative, high-impact research that facilitates regenerative medicine for the benefit of society.
  1. Fueling Biotechnology Partnerships
    Supporting academic partnerships with emerging Canadian regenerative medicine biotechnology companies to bring innovative technologies or therapies to the clinic or market.
  1. Horizon Awards
    Fuelling national multi-disciplinary teams focused on developing transformative technology solutions for tackling significant regenerative medicine challenges.

 

Information to consider for Round 2 funding competition launching September 2022:

  1. SCN has modernized its funding application process for this 2022 competition. The previous application documents have been phased out and replaced with an online application process hosted through the ProposalCentral application portal. All investigators (Lead and Co-investigators) on a team should register and open an account on ProposalCentral prior to initiating an application. ProposalCentral accounts are not required for collaborators or highly qualified personnel (HQP; e.g. graduate students, post-doctoral fellows, technicians or research associates). The lead-investigator’s institutional signing authorities (e.g department or grants administrators) are also required to have a ProposalCentral account in order to sign-off on the submission of the full application.

  2. Letter of Intent
    A Letter of Intent (LOI) submission is mandatory for all SCN funding programs.LOIs will be used to identify peer review requirements, gauge the level of interest in SCN’s programs, and ensure projects fall within SCN’s regenerative medicine mandate.


  3. FAQs and resources
    Read Frequently Asked Questions (FAQs) about the research funding competition.View the online technical briefing webinar:

Download the presentation slides.